The protective effects of pericyte-derived microvesicles on vascular endothelial functions via CTGF delivery in sepsis

• Published in: Cell communication and signaling 2021-11, Vol.19 (1), p.115-20, Article 115
• Main Authors: Zhou, Henan, Zheng, Danyang, Wang, Hongchen, Wu, Yue, Peng, Xiaoyong, Li, Qinghui, Li, Tao, Liu, Liangming
• Format: Article
• Language: English
• Subjects: Abdomen; Angiogenesis; Animals; CD44 antigen; Cell Proliferation - drug effects; Cell-Derived Microparticles - metabolism; Connective tissue growth factor; Connective Tissue Growth Factor - genetics; Connective Tissue Growth Factor - metabolism; CTGF; Cytometry; Endothelial cells; Endothelial Cells - metabolism; Growth factors; Immunofluorescence; Internalization; Intravenous administration; Laboratory animals; Lipopolysaccharides; Lipopolysaccharides - pharmacology; Lung - metabolism; Lung - pathology; Male; Microscopy; Microvesicles; Ostomy; Pericyte; Pericytes; Pericytes - drug effects; Pericytes - metabolism; Phosphorylation; Physiology; Rats; Rats, Sprague-Dawley; Retina; Sepsis; Sepsis - metabolism; Sepsis - pathology; Stat3 protein; STAT3 Transcription Factor - metabolism; Stem cells; Transmission electron microscopy; Veins & arteries
• ISSN: 1478-811X; 1478-811X
• DOI: 10.1186/s12964-021-00795-y

It is well known that sepsis is a prevalent severe disease caused by infection and the treatment strategies are limited. Recently pericyte-derived microvesicles (PMVs) were confirmed to be therapeutic in many diseases, whether PMVs can protect vascular endothelial cell (VEC) injury is unknown. Pericytes were extracted from the retina of newly weaned rats, and PMVs were collected after starvation and characterized by flow-cytometry and transmission electron microscopy. First, the effect of PMVs on pulmonary vascular function in septic rats was measured via intravenous administration with HE staining, immunofluorescence, and Elisa analysis. Then, PMVs were co-incubated with VECs in the presence of lipopolysaccharide (LPS), and observed the protective effect of PMVs on VECs. Next, the proteomic analysis and further Gene Ontology (GO) enrichment analysis were performed to analyze the therapeutic mechanism of PMVs, and the angiogenesis-related protein CTGF was highly expressed in PMVs. Finally, by CTGF upregulation and downregulation in PMV, the role of PMV-carried CTGF was investigated. PMVs restored the proliferation and angiogenesis ability of pulmonary VECs, and alleviated pulmonary vascular leakage in septic rats and LPS-stimulated VECs. Further study showed that PMVs delivered CTGF to VECs, and subsequently activated ERK1/2, and increased the phosphorylation of STAT3, thereby improving the function of VECs. The further study found CD44 mediated the absorption and internalization of PMVs to VECs, the anti-CD44 antibody inhibited the protective effect of PMVs. PMVs may delivery CTGF to VECs, and promote the proliferation and angiogenesis ability by activating the CTGF-ERK1/2-STAT3 axis, thereby protecting pulmonary vascular function in sepsis. The therapeutic effect of PMVs was highly related to CD44-mediated absorption. Video Abstract.